Our Company was originally incorporated as ÂSai ParenteralÂs Private LimitedÂ, a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 12, 2001, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, our Company was converted into a public limited company pursuant to resolution of our Board dated December 24, 2021 and a special resolution of our Shareholders dated January 05, 2022, and consequently, the name of our Company was changed to ÂSai ParenteralÂs Limited and a fresh certificate of incorporation consequent upon conversion to public limited company dated January 17, 2022, was issued to our Company by the RoC.
Major Events and Milestones:
2001
- Company was incorporated as a Private Limited Company under the name of Sai ParenteralÂs Private Limited.
2016
- Change in the ownership of the Company, due to acquisition of Equity Shares by our Promoters from the erstwhile promoters of the Company.
- Acquired Unit-I and Unit-II.
2021
- Launch of Prefilled technology equipment in Unit-I.
2022
- Acquired Unit III and related business from Reichindia Pharma Limited. For details see ÂAcquisition of Business undertaking of Reichindia Pharma Limited on a slump sale basis on page 270.
- Acquired Unit IV and related business from Medreich Limited. For details see ÂAcquisition of Business undertaking of Medreich Limited on a slump sale basis on page 271.
2023
- Incorporated, SP Analytics Private Limited one of our Subsidiary
- Our Company achieved a turnover of ? 1,000 million
2024
- Our Company acquired 100 % shareholding of Revat Laboratories Private Limited, pursuant to which it became a wholly owned subsidiary of our Company.
2025
- Incorporated a wholly owned subsidiary, Sai Parenterals Pte. Limited in Singapore.
- Acquisition of foreign step-down subsidiaries, Noumed Pharmaceuticals Pty Limited in Australia and Noumed Pharmaceuticals Limited in New Zealand.
Click it and Unblock the Notifications
Sign in with Google
